750
Participants
Start Date
Not specified
Study Completion Date
May 31, 1993
Zidovudine
Zalcitabine
NYU Med. Ctr., Dept. of Medicine, New York
Cornell University A2201, New York
Memorial Sloan-Kettering Cancer Ctr., New York
Beth Israel Med. Ctr. (Mt. Sinai), New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Pitt CRS, Pittsburgh
Johns Hopkins Adult AIDS CRS, Baltimore
Unc Aids Crs, Chapel Hill
Duke Univ. Med. Ctr. Adult CRS, Durham
Univ. of Miami AIDS CRS, Miami
The Ohio State Univ. AIDS CRS, Columbus
Case CRS, Cleveland
Univ. of Cincinnati CRS, Cincinnati
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
University of Minnesota, ACTU, Minneapolis
USC CRS, Los Angeles
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
UCSD Maternal, Child, and Adolescent HIV CRS, San Diego
University of Washington AIDS CRS, Seattle
Ucsd, Avrc Crs, San Diego
Ucsf Aids Crs, San Francisco
University of Colorado Hospital CRS, Aurora
Northwestern University CRS, Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
Tulane Hemophilia Treatment Ctr., New Orleans
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans
Brigham and Women's Hosp., Div. of Infectious Disease, Boston
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
Washington U CRS, St Louis
NY Univ. HIV/AIDS CRS, New York
Univ. of Rochester ACTG CRS, Rochester
Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte
Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro
Massachusetts General Hospital ACTG CRS, Boston
HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston
Bmc Actg Crs, Boston
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
NJ Med. School CRS, Newark
Collaborators (1)
Hoffmann-La Roche
INDUSTRY
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH